Bio-based Building Blocks and Polymers – Global Capacities and Trends 2017-2022

100 500  ex. tax

Incl. tax

Strong growth in bio-based building blocks and moderate growth in bio-based polymers

New comprehensive market and trend report “Bio-based Building Blocks and Polymers – Global Capacities and Trends 2017-2022” published by German nova-Institute

The production capacities of bio-based polymers continue to grow at around 3 to 4% per annum, i.e. at about the same rate as petrochemical polymers. Therefore, the market share of bio-based polymers in the total polymer market remains constant at around 2%. But the individual development of different bio-based polymers varies considerably. While some are virtually collapsing compared to previous forecasts (e.g. bio-PET), many are showing constant or slightly increasing capacities and a few are even showing significant growth (such as PLA). Additionally, for some bio-based polymers such as PHA, PEF, bio-PE and bio-PP, the prospects for the future are quite positive. Overall, the market environment remains challenging with low crude oil prices, little political support and partially underutilized capacities. Until now, the biodegradability of some bio-based polymers has not yet been able to generate a real advantage globally.

The new report is more than just an update, it differs from the previous versions in structure and content. It contains comprehensive information on capacity development from 2011 to 2022, per building block and polymer as well as information on 102 individual polymer producers. A total of 17 bio-based building blocks and 15 polymers are covered in the report. In addition, the new issue includes analyses of market developments per building block and polymer, so that readers can quickly gain an overview of developments that go far beyond capacity figures.

Authors
Raj Chinthapalli, Michael Carus, Wolfgang Baltus, Doris de Guzman, Harald Käb, Achim Raschka, Jan Ravenstijn
Date of publication
May 2018
Pages
184
Language
Licences

Single-Site-Licence: Up to five (5) users of the Customer can access the study within one location for their own operational purposes.
Enterprise-Licence: The Customer and all subsidiaries can access the study at all company locations for their own operational purposes. Includes one hour Q&A with nova-experts.

Clear